Periodontal Treatment Response in Type II Diabetic Patients
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Diabetes mellitus affects > 171 million people worldwide, with type II diabetes being the
most prevalent, affecting 85-95% of the diabetic population. Unfortunately, despite
conventional medical treatment, some diabetic patients do not seem to be able to reach
desirable metabolic control. This is a double-blinded, randomized study investigating the
effects of triclosan containing toothpaste (commercial name: Colgate Total) on the response
to periodontal treatment in type II diabetic patients with periodontal disease. The
investigators believe that using triclosan containing toothpaste during periodontal treatment
will decrease the local inflammatory response and that this reduction will improve
periodontal status and metabolic control.